Aker Biomarine AS (AKBM) - Total Liabilities

Latest as of June 2025: Nkr237.50 Million NOK ≈ $24.99 Million USD

Based on the latest financial reports, Aker Biomarine AS (AKBM) has total liabilities worth Nkr237.50 Million NOK (≈ $24.99 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Aker Biomarine AS growing its equity to track the company's year-over-year net asset growth rate.

Aker Biomarine AS - Total Liabilities Trend (2016–2024)

This chart illustrates how Aker Biomarine AS's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Aker Biomarine AS to measure how efficiently the company converts operating cash flow to free cash.

Aker Biomarine AS Competitors by Total Liabilities

The table below lists competitors of Aker Biomarine AS ranked by their total liabilities.

Company Country Total Liabilities
Guilin Fuda Co Ltd
SHG:603166
China CN¥2.16 Billion
Oil-Dri Corporation Of America
NYSE:ODC
USA $123.56 Million
Akcansa Cimento Sanayi ve Ticaret AS
IS:AKCNS
Turkey TL9.02 Billion
ZHEJIANG ASIA-PACIFIC MECHANICAL & ELECTRONIC CO LTD
SHE:002284
China CN¥5.10 Billion
Absci Corp
NASDAQ:ABSI
USA $23.62 Million
Revolve Group LLC
NYSE:RVLV
USA $261.05 Million
Chang Wah Electromaterials Inc
TW:8070
Taiwan NT$17.92 Billion
Henan Yicheng New Energy Co Ltd
SHE:300080
China CN¥8.94 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Aker Biomarine AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Aker Biomarine AS.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.62 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.26 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.59 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.61 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aker Biomarine AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aker Biomarine AS (2016–2024)

The table below shows the annual total liabilities of Aker Biomarine AS from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 Nkr213.50 Million
≈ $22.47 Million
-53.65%
2023-12-31 Nkr460.60 Million
≈ $48.47 Million
+3.32%
2022-12-31 Nkr445.80 Million
≈ $46.91 Million
+15.16%
2021-12-31 Nkr387.12 Million
≈ $40.74 Million
+18.29%
2020-12-31 Nkr327.26 Million
≈ $34.44 Million
-39.13%
2019-12-31 Nkr537.68 Million
≈ $56.58 Million
+113.84%
2018-12-31 Nkr251.43 Million
≈ $26.46 Million
-20.96%
2017-12-31 Nkr318.12 Million
≈ $33.47 Million
+54.94%
2016-12-31 Nkr205.32 Million
≈ $21.61 Million
--

About Aker Biomarine AS

OL:AKBM Norway Packaged Foods
Market Cap
$1.02 Billion
Nkr9.65 Billion NOK
Market Cap Rank
#8693 Global
#66 in Norway
Share Price
Nkr110.00
Change (1 day)
+5.77%
52-Week Range
Nkr76.50 - Nkr113.40
All Time High
Nkr113.40
About

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LY… Read more